Showing results (221-230 of 325) with videos related to

Sort By:
Pageof 33
Biotechnology and Bioengineering|January 15, 2014
Protein products obtained by site-preferred partial crosslinking in protein crystals and "liberated" by redissolutionMichal Buch, Yariv Wine, Yael Dror, et al.
Infection and Immunity|November 14, 1997
Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatusJ A Calera, S Paris, M Monod, et al.
Nutrition Research Reviews|June 24, 2022
The importance of optimal body condition to maximise reproductive health and perinatal outcomes in pigsBruno Bd Muro, Rafaella F Carnevale, Diego F Leal, et al.
Journal of Immunology Research|May 26, 2021
Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in LeishmaniasesLuiza C Reis, Eduardo Milton Ramos-Sanchez, Fernanda N Araujo, et al.
Waste Management (New York, N.Y.)|February 8, 2017
Addition of cattle manure to sheep bedding allows vermicomposting process and improves vermicompost qualityTaiana Cestonaro, Mônica Sarolli Silva de Mendonça Costa, Luiz Antonio de Mendonça Costa, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 8, 2012
The use of workflows in the design and implementation of complex experiments in macromolecular crystallographySandor Brockhauser, Olof Svensson, Matthew W Bowler, et al.
Journal of Biomolecular Structure & Dynamics|September 29, 2015
Molecular dynamics simulations of the free and inhibitor-bound cruzain systems in aqueous solvent: insights on the inhibition mechanism in acidic pHL V B Hoelz, V F Leal, C R Rodrigues, et al.
American Journal of Physiology. Cell Physiology|March 15, 2013
On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cellsMaría V Espelt, Felicitas de Tezanos Pinto, Cora L Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Multicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: results of the GETN(A)-1 trialBruno P Coudert, Remy Largillier, Laurent Arnould, et al.
Pageof 33